Home - Products - Others - Other Targets - H-Phe(4-Cl)-D-Cys-β-(3-pyridyl)-Ala-D-Trp-N-Me-Lys-Thr-Cys-2-Nal-NH2

H-Phe(4-Cl)-D-Cys-β-(3-pyridyl)-Ala-D-Trp-N-Me-Lys-Thr-Cys-2-Nal-NH2

CAS No. 341519-04-8

H-Phe(4-Cl)-D-Cys-β-(3-pyridyl)-Ala-D-Trp-N-Me-Lys-Thr-Cys-2-Nal-NH2( ——— )

Catalog No. M40407 CAS No. 341519-04-8

PRL 3195 is a somatostatin receptor antagonist with Kis of 6, 17, 66, 1000 and 1000 nM for human somatostatin receptors (sst5, sst2, sst3, sst1 and sst4, respectively).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    H-Phe(4-Cl)-D-Cys-β-(3-pyridyl)-Ala-D-Trp-N-Me-Lys-Thr-Cys-2-Nal-NH2
  • Note
    Research use only, not for human use.
  • Brief Description
    PRL 3195 is a somatostatin receptor antagonist with Kis of 6, 17, 66, 1000 and 1000 nM for human somatostatin receptors (sst5, sst2, sst3, sst1 and sst4, respectively).
  • Description
    PRL 3195 is a somatostatin receptor antagonist with Kis of 6, 17, 66, 1000 and 1000 nM for human somatostatin receptors (sst5, sst2, sst3, sst1 and sst4, respectively).
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    hsst5: 6 nM (Ki), hsst2: 17 nM (Ki), hsst3: 66 nM (Ki), hsst1: 1000 nM (Ki), hsst4: 1000 nM (Ki), rat urotensin II receptor: 429 nM (Ki), human urotensin II receptor: 1846 nM (Ki)]
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    341519-04-8
  • Formula Weight
    1177.83
  • Molecular Formula
    C58H69ClN12O9S2
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Rossowski WJ, et al. Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists. Eur J Pharmacol. 2002 Mar 8;438(3):159-70.?
molnova catalog
related products
  • Rebaudioside O

    Rebaudioside O is a stevia glycoside that can be isolated from S. rebaudiana Morita which was selected from S. rebaudiana Bertoni. Rebaudioside O can be used as a sweetener.

  • SDZ285-428

    NVP-VID-400 (SDZ285-428) is a CYP24A1 inhibitor.

  • (Z)-1-Methyl-2-(unde...

    (Z)-1-Methyl-2-(undec-6-enyl)quinolin-4(1H)-one shows strong inhibitory activity on leukotriene biosynthesis in human polymorphonuclear granulocytes, and it is very effective against mycobacteria.